Lacerda GÁJ, Abreu PD, Ripoll PNA

Language: Spanish
References: 11
Page: 1-14
PDF size: 309.55 Kb.

ABSTRACT

Objective: To identify the behavior of the electrolytic and gasometric components of the blood contained in chronic subdural hematomas and to relate them with their growth and expansion.
Methods: A pre-external study was carried out with 20 adult patients surgically treted by chronic subdural hematoma, in the Neurosurgery Service, at Roberto Rodríguez General Teaching Hospital, from Ciego de Ávila, from January to December 2019. The ANOVA test of a single direction was used to determine which sociodemographic variables were related to the results and what hemochemical and gas variables were linked to the growth of the thickness of hematoma. The variables age, sex and Markwalder scale were used, as well as the excess base, pH and PACO2. The Pearson Bivariate Correlation Test was also carried out to evaluate the linear relationship between two variables.
Results: The Markwalder scale at hospitalization evidenced higher incidence of grades II and III, with 7 (35%) and 9 cases (45%), respectively. Those over 60 years (95%) predominated and the volumes of the upper hematoma of 40 cm3 (70%) were more frequent. The Glasgow results scale showed grade V predominance (70%).
Conclusions: Gasometric characteristics showed the decrease of excess base, normal or acid pH and the increase in subdural Blood PACO2. The electrolytic components of the blood seem to have participation in the accumulation and subsequent growth of hematoma.

REFERENCES

1. Iorio-Morin C, Touchette C, Le ´vesque M, Effendi K, Fortin D, Mathieu D. Chronic Subdural Hematoma: Toward a New Management Paradigm for an Increasingly Complex Population. Journal of Neurotrauma. 2018;35:1882-5.

2. Soleman J, Nocera F, Mariani L. The conservative and pharmacological management of chronic subdural haematoma. Swiss Med Wkly. 2017;147:w14398.

3. Min Jang K, Ho Choi H, Yong Mun H, Kyun Nam T, Sook Park Y, Taik Kwon J. Critical Depressed Brain Volume Infuences the Recurrence of Chronic Subdural Hematoma after Surgical Evacuation. Scientific Reports. 2020;10:1145.

4. Almenawer SA, Farrokhyar F, Hong C, Alhazzani W, Manoranjan B, Yarascavitch B, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34 829 patients. Ann. Surg. 2014;259:449-5.

5. Mehta V, Harward SC, Sankey EW, Nayar G, Codd PJ. Evidence based diagnosis and management of chronic subdural hematoma: A review of the literature. Journal of clinical neuroscience. 2018;50:7-15.

6. Holl DC, Volovici V, Clemens MFD, Wilco CP, van Kooten F, Jellema K, et al. Pathophysiology and Nonsurgical Treatment of Chronic Subdural Hematoma: From Past to Present to Future. World Neurosurg. 2018;116:402-11.

7. Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural hematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 2017;14:108.

8. Fu S, Li F, Bie L. Drug therapy for chronic subdural hematoma: bench to bedside. J Clin Neurosci. 2017;56:16-20.

9. Miah IP, Herklots M, Roks G, Peul WC, Walchenbach R, Dammers R, et al. Dexamethasone Therapy in Symptomatic Chronic Subdural Hematoma (DECSA–R): A Retrospective Evaluation of Initial Corticosteroid Therapy versus Primary Surgery. Journal of Neurotrauma. 2020;37(2):366-72. Doi: https://doi.org/10.1089/neu.2019.6541

10. Frati A, Salvati M, Mainiero F, Ippoliti F, Rocchi G, Raco A, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg. 2004;100(1):24-32.

11. Mei Chen F, Wang K, Li Xu K, Wang L, Xiang Zhan T, Cheng F, et al. Predictors of acute intracranial hemorrhage and recurrence of chronic subdural hematoma following burr hole drainage. BMC Neurology. 2020;20:92.